Electrophysiological and anatomical factors determine arrhythmic risk in acute myocardial ischaemia and its

Hector Martinez-Navarro1, Xin Zhou1, Alfonso Bueno-Orovio1

  • 1Department of Computer Science, British Heart Foundation Centre of Research Excellence, University of Oxford, Parks Road, Oxford OX1 3QD, UK.

Interface Focus
|December 18, 2020
PubMed

Insights

Reduced sodium current availability increases arrhythmia risk during acute myocardial ischemia. This is due to electrophysiological changes and anatomical factors, particularly in the ventricles, highlighting key mechanisms of sudden cardiac death.

Area of Science:

  • Cardiovascular Physiology
  • Computational Biology
  • Medical Simulation

Background:

  • Acute myocardial ischemia is a primary cause of sudden cardiac death.
  • Reduced sodium current availability, from mutations or other factors, is linked to increased arrhythmia risk in ischemic patients, but mechanisms remain unclear.

Purpose of the Study:

  • To investigate arrhythmia mechanisms in acute myocardial ischemia with variable sodium current availability.
  • To utilize high-performance computing simulations for precise control and data transparency.

Main Methods:

  • Employed a human anatomically based torso-biventricular electrophysiological model.
  • Incorporated realistic ventricular anatomy, fiber architecture, and ionic to electrocardiographic properties.
  • Conducted over 300 high-performance computing simulations.

Main Results:

  • Reduced sodium current availability exacerbated arrhythmic risk in acute regional ischemia.
  • Electrophysiological factors (dispersion of refractoriness) and anatomical factors (ventricular asymmetry, conduction block) contributed to risk.
  • Asymmetric ventricular anatomy increased risk for right ventricular and basal ectopic stimuli; increased sodium availability was ineffective for septo-basal excitations.

Conclusions:

  • Human-based multiscale modeling identified key electrophysiological and anatomical determinants of arrhythmic risk in ischemia with altered sodium current.
  • Findings provide insights into mechanisms underlying sudden cardiac death in ischemic heart disease.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.4K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.3K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
8.2K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
226
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.6K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.0K